Real-life efficacy and safety of omalizumab in Portuguese patients with persistent uncontrolled asthma

Conclusion The findings from the Portugal subpopulation of eXpeRience registry confirm that omalizumab add-on therapy is efficacious and well tolerated in the management of uncontrolled persistent allergic asthma. Another pertinent issue is the fact that the Portuguese subpopulation response is similar to the international population average of the study.
Source: Revista Portuguesa de Pneumologia - Category: Respiratory Medicine Source Type: research